• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 949

Bacillus coagulans strain DSM 17654 spore preparation

Intended Use: Intended for use at a maximum level of 2 x 109 colony forming units (CFU)/serving as an ingredient in baked goods and baking mixes; breakfast cereals; beverages and beverage bases; coffee and tea; milk and milk products; dairy product analogs; fruit juices; condiments and relishes; confections and frostings; frozen dairy desserts and mixes; fruit and water ices; jams and jellies; gelatins, puddings and fillings; grain products and pastas; hard and soft candy; chewing gum; extracts, flavorings, herbs, seeds, spices, seasonings and blends; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soups and soup mixes; sugar; and sweet sauces, toppings and syrups (excluding infant formula, foods formulated for infants, or any products under the jurisdiction of the United States Department of Agriculture).
Basis: Scientific procedures
Notifier: Advanced Enzymes Technologies Ltd.
Notifier Address: 5th Floor, A wing, Sun Magnetica
L.I.C. Service Road, Louiswadi
Thane (W) 400 064
GRAS Notice (releasable information): GRN 949 with amendments (in PDF) (21.4 MB)
Date of closure: Jan 7, 2021
FDA's Letter: FDA has no questions (in PDF)